Earnings Call · Q4 FY2021·2022-03-22

Q4 21EPS +23.96%·Rev n/aQ3 21EPS +7.69%·Rev n/aQ2 21EPS +30.88%·Rev n/aQ1 21EPS -100.00%*·Rev n/a⚠ consensus missing

LISATA THERAPEUTICS, INC. LSTA

John Menditto — Management Team Member

David Mazzo — President and Chief Executive Officer

James Nisco — Financial Officer

Kristen Buck — Management Team Member

−2.0%1d on move date−0.7% vs SPY3d+2.8%5d+2.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LSTA calls or request research access.

More LSTA calls Browse calls Request research access